Search

everythinglearnresearchcommunity

for

Search:↓

PRAME helps distinguish between benign and malignant skin cells in most cases.

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

ABCG2 protein marks stem-like skin cells in human epidermis.

GLI1 RNA CISH effectively identifies basal cell carcinoma but is less specific for benign follicular tumors.

KRT80 may worsen cancer by increasing growth and spread, but its full effects on treatment and outcomes need more research.

Using a combination of specific cell cycle regulators is better for safely keeping hair root cells alive indefinitely compared to cancer-related methods.

Krt15+ cells in mice can resist radiation, regenerate tissue, and start tumors, suggesting new cancer treatment targets.

CK 19 expression is higher in more severe skin cancers.

Lipid-antigen stimulation may play a role in folliculotropic mycosis fungoides.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

Mitochondrial features can predict colorectal cancer outcomes and improve immunotherapy.

CTIP2 may help in skin development and maintenance.

mrp/plf-mRNA can indicate tumor-promoting effects in skin.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

OCT4B1 and SOX-2 levels are higher in Crohn's and ulcerative colitis patients, possibly aiding tissue repair.

CD27 and IL-35 can help diagnose alopecia areata linked to bacterial infections.

Cytokeratins 15 and 19 may help track vitiligo treatment progress.

CD271 is crucial for maintaining healthy skin and preventing inflammation.

Recognizing RSCC is crucial due to its aggressive nature and high risk of poor outcomes.

CD80 on skin stem cells helps expand Treg cells to aid wound healing.

K31 can identify clear secretory cells in human sweat glands.

c-Kit is important for heart regeneration and cancer development.

RAR-gamma 1 is important for normal skin maintenance and differentiation.

CD1d expression in scalp skin and hair follicles changes with the hair cycle and may help protect against microbes.

TB and BCC tumors show similar follicular differentiation patterns.

PCFCL may have unrecognized subtypes and needs more research.

CD200 is not a reliable marker for identifying stem cells in all skin types.